Absence seizures are most effectively treated with medication, and the majority of children and adults achieve good seizure control with the right drug. The first-line choice for typical absence seizures is ethosuximide, which controls seizures in roughly 53% of children within the first 16 weeks. Valproate works equally well at about 58%, and the choice between the two depends on whether other seizure types are also present.
How Absence Seizures Are Diagnosed
Before treatment begins, a doctor needs to confirm the diagnosis with an EEG (a test that records electrical activity in the brain). Absence seizures produce a distinctive pattern called spike-and-wave discharges, which start at about 3.5 to 4 cycles per second and slow to 2.5 to 3 cycles per second as each burst resolves. This pattern is the primary diagnostic criterion and distinguishes absence seizures from other types of brief staring episodes, like focal seizures or simple daydreaming.
The EEG also helps determine whether someone has typical or atypical absence seizures, which matters because the treatment approach differs. In some cases, a doctor will ask the patient to hyperventilate during the EEG, since deep breathing reliably triggers absence seizures and makes them easier to capture on the recording.
First-Line Medications
If someone has only absence seizures with no other seizure types, ethosuximide is the preferred starting medication. It has the best balance of effectiveness and tolerability. According to a landmark trial published in the New England Journal of Medicine, ethosuximide and valproate produced similar seizure-freedom rates (53% and 58% respectively after 16 weeks), but ethosuximide caused fewer problems with attention, a significant advantage for school-age children.
Valproate becomes the better first choice when absence seizures occur alongside generalized tonic-clonic seizures (the type involving full-body convulsions). Ethosuximide does not protect against tonic-clonic seizures and can potentially make them worse. This is an important distinction: if a child or teenager has ever had a tonic-clonic seizure in addition to absence episodes, doctors will typically start with valproate instead.
Lamotrigine is sometimes listed as a first-line option in guidelines, but the evidence shows it is significantly less effective. In the same trial, only 29% of patients on lamotrigine were seizure-free at 16 weeks, roughly half the rate of the other two drugs. It is more commonly used as a second-line option or added to another medication when the first one isn’t enough on its own.
How These Medications Work
Absence seizures originate from abnormal rhythmic signaling between the thalamus (a relay station deep in the brain) and the cortex (the brain’s outer surface). Specific calcium channels in thalamic neurons fire in rapid, repetitive bursts, creating an oscillating loop that produces the characteristic 3-per-second spike-and-wave pattern on EEG. During these bursts, normal awareness is briefly interrupted.
Ethosuximide works by blocking these calcium channels in thalamic neurons, which suppresses the repetitive burst firing and prevents the oscillating loop from starting. This targeted mechanism explains why the drug is so effective for absence seizures specifically, and also why it does nothing for other seizure types that arise from different brain circuits.
Typical vs. Atypical Absence Seizures
Typical absence seizures, the kind most common in childhood, generally respond well to ethosuximide or valproate. Atypical absence seizures tend to occur in the context of more complex epilepsy syndromes like Lennox-Gastaut syndrome, and they are harder to control. These episodes may last longer, start and stop more gradually, and involve more noticeable changes in muscle tone.
Atypical absence seizures respond to many of the same medications, but valproate is more commonly used than ethosuximide because children with these seizures almost always have other seizure types as well. Some medications that are safe for typical absences can actually worsen atypical ones. Carbamazepine and phenytoin, two common epilepsy drugs, should be avoided because they can aggravate absence seizures of both types.
For atypical absences that don’t respond to standard treatment, rufinamide has shown promise. In a controlled trial of 139 patients, it reduced atypical absence seizure frequency by about 51%, compared to 30% with placebo.
When the First Medication Doesn’t Work
If ethosuximide alone doesn’t bring seizures under control, valproate is often added alongside it to improve the odds. When neither drug alone or in combination achieves full seizure control, doctors may trial lamotrigine or other broad-spectrum options. The goal is always to find the lowest effective dose of the fewest medications.
For children with drug-resistant absence epilepsy, the ketogenic diet is a well-studied alternative. This high-fat, very-low-carbohydrate diet changes how the brain metabolizes energy and has a meaningful effect on seizure activity. A review of 133 patients with absence epilepsy found that about 69% had their seizures reduced by more than half on the diet, and 34% became completely seizure-free. The diet requires medical supervision and careful nutritional planning, but it offers a real option when medications fall short.
Side Effects to Expect
Ethosuximide’s most common side effects are gastrointestinal: nausea, stomach discomfort, and reduced appetite, especially when first starting the medication. These often improve after the first few weeks. Importantly, ethosuximide tends to have less impact on attention and cognitive function compared to valproate, which is why it’s preferred as the starting drug for children who are in school.
Valproate carries a broader side effect profile. It can cause weight gain, tremor, and hair thinning. It also poses serious risks during pregnancy, making it a less ideal long-term choice for girls and women of childbearing age. Lamotrigine is generally well-tolerated but requires a very slow dose increase to reduce the risk of a serious skin reaction.
How Long Treatment Lasts
Most children with absence epilepsy will take medication for several years. The standard guideline is that tapering off medication can be considered after at least two seizure-free years. The longer someone goes without a seizure, the lower the risk of recurrence after stopping medication. That said, the two-year mark is a starting point, not a rigid rule. Doctors weigh individual factors like the type of epilepsy syndrome, EEG findings, and whether other seizure types have occurred before deciding when to begin reducing the dose.
Many children with childhood absence epilepsy outgrow their seizures by adolescence. Juvenile absence epilepsy, which starts later (typically around ages 10 to 17), is more likely to persist into adulthood and may require longer or even lifelong treatment.
Safety Precautions During Treatment
Even brief lapses in awareness can be dangerous in certain situations. Water is the biggest concern: the most common place children and adults with epilepsy drown is in a bathtub. Children with active seizures should shower rather than bathe once they’re old enough, and the bathroom door should stay unlocked. Younger children need continuous hands-on supervision during any bath.
Swimming is still possible, but it requires specific precautions. Your child should always swim in a supervised pool, never alone. The lifeguard should know about the seizures, and an additional adult who is focused solely on watching your child should be present. Open water like lakes and rivers is riskier and should only be attempted with a life jacket and close supervision. Water shallow enough for the supervising adult to stand comfortably is safest.
For teenagers and adults, driving restrictions vary by state and country but generally require a period of seizure freedom, often six months to a year, before a license is granted or reinstated. Activities at heights, operating heavy machinery, and cycling in traffic all carry elevated risk during periods of uncontrolled seizures.